Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
J. Vivancos
2397  Ergebnisse:
Personensuche X
?
1

49P A ctDNA tool for identifying ESR1-mutated biology in ES..:

Fructuoso, I. Garcia ; Martínez-Sáez, O. ; Pardo, F....
ESMO Open.  9 (2024)  - p. 103056 , 2024
Link: https://doi.org/10.1016/..
 
?
2

76P Association of clinicopathological (C-P) features and t..:

Salvà Ballabrera, F. ; Garcia-Galea, E. ; Comas, R....
Annals of Oncology.  35 (2024)  - p. S37-S38 , 2024
Link: https://doi.org/10.1016/..
 
?
3

8P Evaluating HER2DX pCR-Score and MRI response in predicti..:

Pascual, T. ; Martínez-Sáez, O. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103017 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Asociación entre periodontitis, enfermedad cerebrovascular ..:

Leira, Y. ; Vivancos, J. ; Diz, P....
Neurología.  39 (2024)  3 - p. 302-311 , 2024
Link: https://doi.org/10.1016/..
 
?
5

93P Evolving landscape of targeted therapies (TT) in early ..:

Rossi, A. ; Braña, I. ; Villar, M. Vieito...
ESMO Open.  9 (2024)  - p. 102319 , 2024
Link: https://doi.org/10.1016/..
 
?
6

14P Assessing the predictive value of HER2DX pCR-score for ..:

Martínez-Sáez, O. ; Marin, M. ; Brunet, L. Pare...
ESMO Open.  9 (2024)  - p. 103023 , 2024
Link: https://doi.org/10.1016/..
 
?
7

First detection and genomic characterisation of Spinach lat..:

Javaran, V. J. ; Poursalavati, A. ; Lemoyne, P...
New Disease Reports.  49 (2024)  1 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
8

1MO HER2DX assay and survival outcomes: An individual-patie..:

Javierre, G. Villacampa ; Cortés, J. ; García, J.M. Pérez...
ESMO Open.  9 (2024)  - p. 103011 , 2024
Link: https://doi.org/10.1016/..
 
?
9

125P Circulating tumour DNA (ctDNA) as a prognostic biomark..:

Saoudi Gonzalez, N. ; Navarro Garces, V. ; Salvà Ballabrera, F....
Annals of Oncology.  35 (2024)  - p. S58-S59 , 2024
Link: https://doi.org/10.1016/..
 
?
10

472P Homologous-recombination deficiency (HRD) in gastroeso..:

Acosta Eyzaguirre, D. ; Castillo, G. ; Aguilar Izquierdo, S....
Annals of Oncology.  35 (2024)  - p. S189 , 2024
Link: https://doi.org/10.1016/..
 
?
11

166P Clinical use of tumor sequencing for identification of..:

Lapena, M. Cruellas ; Papakonstantinou, A. ; Castillo, E....
ESMO Open.  9 (2024)  - p. 103188 , 2024
Link: https://doi.org/10.1016/..
 
?
12

The association between periodontitis and cerebrovascular d..:

Leira, Y. ; Vivancos, J. ; Diz, P....
Neurología (English Edition).  39 (2024)  3 - p. 302-311 , 2024
Link: https://doi.org/10.1016/..
 
?
13

Prognostic value of HER2DX in early-stage HER2-positive bre..:

Villacampa, G. ; Pascual, T. ; Brasó-Maristany, F....
ESMO Open.  9 (2024)  3 - p. 102388 , 2024
Link: https://doi.org/10.1016/..
 
?
14

102P HER2DX risk-score in early-stage HER2-positive (HER2+)..:

Pascual, T. ; Villacampa, G. ; Brasó-Maristany, F....
ESMO Open.  8 (2023)  1 - p. 101326 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Plasmatic BRAF-V600E allele fraction as a prognostic factor..:

Ros, J. ; Matito, J. ; Villacampa, G....
Annals of Oncology.  34 (2023)  6 - p. 543-552 , 2023
Link: https://doi.org/10.1016/..
 
1-15